Yuanjie Niu

4PUBLICATIONS
27CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - proteins and peptides (incl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 23, 2025
SREBF1-based metabolic reprogramming in prostate cancer promotes tumor ferroptosis resistance.

Guojiang Wei, Ying Huang, Wenya Li

|Jan 08, 2025
Phase II Pilot Trial of Tislelizumab plus Low-Dose Nab-Paclitaxel for Extensive Very High-Risk Non-Muscle-Invasive Bladder Cancer.

Yunkai Qie, Shiwang Huang, Chong Shen

|Oct 15, 2024
Relationships of dietary habits with prostate cancer risk: results from Mendelian randomization analyses and the National Health and Nutrition Examination Survey.

Zhen Zhou, Jin Xu, Yang Zhao

|Aug 18, 2024
Monoacylglycerol lipase blockades the senescence-associated secretory phenotype by interfering with NF-κB activation and promotes docetaxel efficacy in prostate cancer.

Jianpeng Yu, Minghao Zhang, Taipeng Li

Pageof 1

Frequent Collaborators

2 joint publications

Yang Zhao

1 joint publications

Jianpeng Yu

1 joint publications

Zhiqun Shang

1 joint publications

Yunkai Qie